| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/21/2002 | CA2418087A1 Use of microbial dna sequences for the identification of human diseases |
| 02/21/2002 | CA2417152A1 Therapeutic compounds for ovarian cancer |
| 02/21/2002 | CA2417141A1 Novel glycoproteins and methods of use thereof |
| 02/20/2002 | EP1180686A1 Remedies for kidney diseases and method for screening the same |
| 02/20/2002 | EP1180546A1 Human cell line showing stable expression of cytochromes p450 |
| 02/20/2002 | EP1180525A1 Transcriptional activation inhibitory protein |
| 02/20/2002 | EP1180524A1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
| 02/20/2002 | EP1180168A1 MOLECULAR CHARACTERISATION OF CHROMOSOME TRANSLOCATION t(11;18)(q21;q21) AND ITS CORRELATION TO CARCINOGENESIS |
| 02/20/2002 | EP1180159A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in tnf-associated disorders |
| 02/20/2002 | EP1180155A1 Vector for integration of heterologous sequences into poxviral genomes |
| 02/20/2002 | EP1180154A1 PROMOTER OF THIOREDOXINE TaTrxh2 IN WHEAT |
| 02/20/2002 | EP1180152A1 Recombinant bacterial phytases and uses thereof |
| 02/20/2002 | EP1180151A2 Protein kinases |
| 02/20/2002 | EP1180147A1 Secreted alpha-helical protein-31 |
| 02/20/2002 | EP1180144A2 Cytoskeleton-associated proteins |
| 02/20/2002 | EP1180143A2 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 02/20/2002 | EP1180142A2 Methods and compositions for measuring ion channel conductance |
| 02/20/2002 | EP1180141A2 The p2x 3 receptor, methods of altering p2x 3receptor activity and uses thereof |
| 02/20/2002 | EP1180134A1 Multi- applicable cell-culture method and apparatus |
| 02/20/2002 | EP1180117A1 Models of prion disease |
| 02/20/2002 | EP1180042A1 Model membrane systems |
| 02/20/2002 | EP1180037A2 Therapeutic uses of agents that modulate the activity of alpha-smooth muscle actin |
| 02/20/2002 | EP1180036A1 Cell therapy for chronic stroke |
| 02/20/2002 | EP1180000A1 Prosthetic grafts |
| 02/20/2002 | EP0874992B1 Compounds and methods for the detection and prevention of t. cruzi infection |
| 02/20/2002 | EP0667904B1 Suppressor and progenitor cells |
| 02/20/2002 | CN1336959A Method for introducing substances into cells and use of said method |
| 02/20/2002 | CN1336958A Pyruvate carboxylase from i(Corynebacterium glutamicum) |
| 02/20/2002 | CN1336957A BASB006 polynucleotide(s) and polypeptides from neisseria meningitis |
| 02/20/2002 | CN1336796A Method of constructing male sterile plant |
| 02/20/2002 | CN1336431A Establishment of immortal human ovary carcinoma cell strain |
| 02/20/2002 | CN1336381A Trichosanthin mutant and its prepn. |
| 02/19/2002 | US6348643 For transgenic plants with improved herbicide resistance especially for imidazolinone herbicides |
| 02/19/2002 | US6348641 Purified proteins, recombinant DNA sequences and processes for producing caffeine-free beverages |
| 02/19/2002 | US6348583 Nucleobase containing polythioethers synthesized on polyethylene glycol, succinic anhydride and propylamine modified glass; nucleic acid mimetics |
| 02/19/2002 | US6348579 FtsL |
| 02/19/2002 | US6348576 Human cornichon molecule |
| 02/19/2002 | US6348574 An antibody; diagnosis and therapy for tumors, strokes, vasoconstriction, bronchial asthma, and atherosclerosis |
| 02/19/2002 | US6348486 Methods for modulating bladder function |
| 02/19/2002 | US6348446 Harvesting hematopoietic cells from mammal expressing cd77.sup.+ cells, treating cells with lethal dose of unconjugated shiga-toxin or shiga-like toxin-1 for sufficient time to kill cd77.sup.+ cells, thus purging from population |
| 02/19/2002 | US6348353 Artificial mammalian chromosome |
| 02/19/2002 | US6348352 Purging tumor cells from a hematopoietic progenitor cell population by introducing a stable tumor suppressor gene into a heterogeneous cell population and selectively transducing phenotypically hyperproliferative cells |
| 02/19/2002 | US6348351 Tie receptor tyrosine kinase ligand homologues |
| 02/19/2002 | US6348349 A rodent embryonic stem cell transformed with yeast artifical chromosomes, with introducing yeast dna; for efficient transformations |
| 02/19/2002 | US6348344 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same |
| 02/19/2002 | US6348334 DNA encoding Fas ligand |
| 02/19/2002 | US6348329 Isolation of polynucleotide sequence codes of polypeptide with amino acid sequences |
| 02/19/2002 | US6348327 Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells |
| 02/19/2002 | CA2215343C Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders |
| 02/19/2002 | CA2141060C Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods |
| 02/19/2002 | CA2023246C Mutants of human interleukin-3 |
| 02/18/2002 | CA2354653A1 Peptide mutant of human erab/hadh2, its x-ray crystal structure, and materials and method for identification of inhibitors thereof |
| 02/17/2002 | CA2355340A1 Process for inducing direct somatic embryogenesis and secondary embryogenesis in monocotyledonous plant cells, and rapidly regenerating fertile plants |
| 02/14/2002 | WO2002012899A2 Peptides presented by cells |
| 02/14/2002 | WO2002012539A2 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 02/14/2002 | WO2002012537A2 Mutant trichosanthin |
| 02/14/2002 | WO2002012525A2 Helper functions for recombinant vector production |
| 02/14/2002 | WO2002012523A2 Transduction of chondrocytes using adenoviral vectors |
| 02/14/2002 | WO2002012520A1 Method of improving gene transfer efficiency into plant cells |
| 02/14/2002 | WO2002012515A1 Assays for alternative lengthening of telomeres |
| 02/14/2002 | WO2002012506A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 02/14/2002 | WO2002012502A2 Anti-tnf antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012501A2 Anti-dual integrin antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012500A2 Anti-il-12 antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012477A2 Enhanced replication of hcv rna |
| 02/14/2002 | WO2002012470A2 A member of the lysyl oxidase gene family |
| 02/14/2002 | WO2002012467A2 Drug metabolizing enzymes |
| 02/14/2002 | WO2002012466A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
| 02/14/2002 | WO2002012465A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
| 02/14/2002 | WO2002012464A2 Mutant trichoderma reesei egiii cellulases dna encoding such egiii compositions and methods for obtaining same |
| 02/14/2002 | WO2002012463A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
| 02/14/2002 | WO2002012462A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
| 02/14/2002 | WO2002012461A2 Regulation of human membrane-type serine protease |
| 02/14/2002 | WO2002012456A2 Ampk-related serine/threonine kinase, designated snark |
| 02/14/2002 | WO2002012453A1 Method for reducing specific immune reactions |
| 02/14/2002 | WO2002012452A2 Pancreatic progenitor cells |
| 02/14/2002 | WO2002012451A1 Method of culturing human chondrocytes |
| 02/14/2002 | WO2002012449A1 Regeneration of rose plants from embryogenic callus |
| 02/14/2002 | WO2002012448A1 Methods for culturing human lung mast cells and uses thereof |
| 02/14/2002 | WO2002012447A2 Isolation and use of solid tumor stem cells |
| 02/14/2002 | WO2002012441A2 Cryopreservation of sperm |
| 02/14/2002 | WO2002012435A1 Method of producing infectious reovirus |
| 02/14/2002 | WO2002012345A2 Soluble zcytor 11 cytokine receptors |
| 02/14/2002 | WO2002012341A2 Her-2/neu fusion proteins |
| 02/14/2002 | WO2002012340A2 Transporters and ion channels |
| 02/14/2002 | WO2002012339A2 Sequences for integrin alpha-8 |
| 02/14/2002 | WO2002012333A1 Potential growth factors from the human tumour cell line ht1080 |
| 02/14/2002 | WO2002012326A2 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
| 02/14/2002 | WO2002012325A2 Suppressor gene |
| 02/14/2002 | WO2002012307A1 Urocortin proteins and uses thereof |
| 02/14/2002 | WO2002012290A2 Sid polypeptides binding to pathogenic strain of the hepatitis c virus |
| 02/14/2002 | WO2002012286A2 Stress proteins and peptides and methods of use thereof |
| 02/14/2002 | WO2002012281A2 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen |
| 02/14/2002 | WO2002012279A2 Schizophrenia related gene and protein |
| 02/14/2002 | WO2002012275A2 Lat peptides and their use in assays for identifying immunosuppressants |
| 02/14/2002 | WO2002012274A2 Iapl-3 a protein inhibitor of apoptosis proteins |
| 02/14/2002 | WO2002012272A2 Therapeutic anti-melanoma compounds |
| 02/14/2002 | WO2002012268A1 Motor proteins and methods for their use |
| 02/14/2002 | WO2002012262A1 IDENTIFICATION OF cDNAs ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA |
| 02/14/2002 | WO2002011785A2 Manipulation of arterial-venous identity |